| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
INS-IGF2 readthrough | 0.633 | 0.500 | 5.6E-02 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2007 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
synaptophysin | 0.481 | 0.808 | 0.92 |
|
disease | 0.300 | None | 0.970 | 1 | 0 | 1996 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.300 | None | 0.982 | 1 | 0 | 1989 | 2020 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
BCL2 like 2 | 0.599 | 0.615 | 0.47 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2004 | 2010 | ||||||||
|
neuroglobin | 0.631 | 0.462 | 4.5E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.300 | None | 0.960 | 1 | 0 | 1997 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 1 | 0.460 | 0.885 | 6.2E-07 |
|
disease | 0.280 | None | 1.000 | 1 | 0 | 1997 | 2017 | ||||||||
|
ATPase copper transporting alpha | 0.494 | 0.769 | 1.00 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2009 | 2015 | ||||||||
|
mitofusin 2 | 0.471 | 0.846 | 0.99 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2009 | 2019 | ||||||||
|
microtubule associated protein 2 | 0.537 | 0.692 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1991 | 2019 | ||||||||
|
glutathione-disulfide reductase | 0.494 | 0.846 | 1.3E-06 |
|
disease | 0.240 | None | 1.000 | 1 | 0 | 1998 | 2018 | ||||||||
|
glyceraldehyde-3-phosphate dehydrogenase | 0.447 | 0.808 | 0.11 |
|
disease | 0.300 | None | 0.895 | 1 | 0 | 1994 | 2018 | ||||||||
|
beta-secretase 1 | 0.559 | 0.769 | 0.88 |
|
disease | 0.600 | None | 0.985 | 1 | 0 | 1999 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.978 | 1 | 0 | 1999 | 2019 | ||||||||
|
dynamin 1 | 0.595 | 0.692 | 1.00 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2003 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.300 | None | 0.972 | 1 | 0 | 1998 | 2019 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2020 | ||||||||
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.240 | None | 0.800 | 1 | 0 | 2004 | 2019 | ||||||||
|
choline O-acetyltransferase | 0.520 | 0.808 | 5.6E-11 |
|
disease | 0.300 | None | 0.981 | 1 | 0 | 1987 | 2019 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
calcium and integrin binding 1 | 0.458 | 0.769 | 3.3E-04 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
cyclin dependent kinase 5 | 0.495 | 0.846 | 0.14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2020 | ||||||||
|
heat shock transcription factor 1 | 0.507 | 0.769 | 0.75 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2013 | 2018 |